| 4I2P: reference: A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants., Johnson BC, Pauly GT, Rai G, Patel D, Bauman JD, Baker HL, Das K, Schneider JP, Maloney DJ, Arnold E, Thomas CJ, Hughes SH, Retrovirology. 2012 Dec 5;9(1):99. PMID: 23217210 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).